Treatment of leukemia with low-dose ara-C: a study of 160 cases
Degos, L.; Castaigne, S.; Tilly, H.; Sigaux, F.; Daniel, M.T.
Seminars in Oncology 12(2 Suppl 3: 196-199
1985
ISSN/ISBN: 0093-7754 PMID: 4012337 Document Number: 246163
Document emailed within 1 workday
Related Documents
Huang, M.E.; Ye, Y.C.; Zhao, L. 1987: Treatment of acute promyelocytic leukemia by retinoic acid with or without low dose cytosine arabinoside: report of 4 cases Zhonghua Nei Ke Za Zhi 26(6): 330Okamoto, T.; Kanamaru, A.; Shimazaki, C.; Motoji, T.; Takemoto, Y.; Takahashi, M.; Fukushima, T.; Takeshita, A.; Kusumoto, G.S.; Kishimoto, Y.; Yorimitsu, S.; Tsukuda, K.; Uike, N.; Arima, N.; Ohno, R. 2000: Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis International Journal of Hematology 72(2): 200-205
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Wu, S.Q.; Zhang, Q.Z.; Gu, Y.Y. 1985: The cytogenetic study of 83 cases of chronic myeloid leukemia with a report of 7 special cases Zhonghua Nei Ke Za Zhi 24(12): 735
Petrini, M.; Caracciolo, F.; Corini, M.; Valentini, P.; Sabbatini, A.R.; Grassi, B. 1991: Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study Haematologica 76(3): 200-203
Waage, A.; Hammerstrøm, J.; Lødemel, B.; Hoff, J.E.; Langtind, J. 1986: Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(6): 496-497
Klener, P.; Háber, J. 1985: Treatment of refractory leukemia with high-dose cytosine arabinoside Neoplasma 32(1): 113-117
Takeyama, H.; Yano, K.; Ohoshima, K.; Satake, T.; Emi, N.; Sugihara, T.; Kawashima, K. 1983: Small dose of ARA-C in the treatment of an elderly patient with acute myeloblastic leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(11): 2418-2422
Wang, J.J.; Freeman, A.I.; Sinks, L.F. 1976: Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate Cancer Research 36(4): 1441-1444
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Julien, G.; Pochet, P.; Cure, H.; Legros, M. 1990: Treatment with high-dose immunoglobulins of erythroblastopenia secondary to chronic lymphoid leukemia Presse Medicale 19(3): 134
Van Echo, D.A.; Wiernik, P.H.; Aisner, J. 1980: High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia Cancer Clinical Trials 3(4): 325-328
Kawano, F.; Nishimura, Y.; Tsukamoto, A.; Satoh, M.; Sanada, I.; Shido, T. 1992: Successful treatment with low dose Ara-C in de novo acute myeloid leukemia with trilineage myelodysplasia International Journal of Hematology 55(1): 101-102
Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Chen, G.Q.; Shen, Z.X.; Wu, F.; Han, J.Y.; Miao, J.M.; Zhong, H.J.; Li, X.S.; Zhao, J.Q.; Zhu, J.; Fang, Z.W.; Chen, S.J.; Chen, Z.; Wang, Z.Y. 1996: Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia Leukemia 10(5): 825-828
Hiçsönmez, G.; Ozsoylu, S.; Tuncer, M.; Erer, B. 1988: High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement Turkish Journal of Pediatrics 30(3): 181-183
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109
Sutoh, H.; Yamauchi, T.; Gotoh, N.; Sugiyama, M.; Ueda, T. 2003: Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia Anticancer Research 23(6d): 5037-5042
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242